Cargando…
Drug-induced cholestasis assay in primary hepatocytes
Drug-induced cholestasis (DIC) is a major cause of clinical failure of drug candidates. Numerous patients worldwide are affected when exposed to marketed drugs exhibiting a DIC signature. Prospective identification of DIC during early compound development remains challenging. Here we describe the op...
Autores principales: | Van Brantegem, Pieter, Chatterjee, Sagnik, De Bruyn, Tom, Annaert, Pieter, Deferm, Neel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559231/ https://www.ncbi.nlm.nih.gov/pubmed/33088729 http://dx.doi.org/10.1016/j.mex.2020.101080 |
Ejemplares similares
-
Cholestasis Differentially Affects Liver Connexins
por: Cooreman, Axelle, et al.
Publicado: (2020) -
Case Report: Bosentan and Sildenafil Exposure in Human Milk - A Contribution From the ConcePTION Project
por: Nauwelaerts, Nina, et al.
Publicado: (2022) -
Drug‐induced cholestasis
por: Sundaram, Vinay, et al.
Publicado: (2017) -
Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid
por: Van Daele, Ruth, et al.
Publicado: (2021) -
Development of a Pig Mammary Epithelial Cell Culture Model as a Non-Clinical Tool for Studying Epithelial Barrier—A Contribution from the IMI-ConcePTION Project
por: Bernardini, Chiara, et al.
Publicado: (2021)